Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)
Clinical trial NCT05529524 · COMPLETED
Trial details
- NCT number
- NCT05529524
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-07
- Primary completion
- 2024-01-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.